~~<i id='4F5BB84164'><strike id='4F5BB84164'><tt id='4F5BB84164'><pre id='4F5BB84164'></pre></tt></strike></i>~~

Home» comprehensive» Wikipedia

Wikipedia

author：explore 2025-09-29 04:48:00 Page View：8716

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Grand jury probing Trump's efforts to overturn 2020 election did not meet Friday: Sources
Next article： Supreme Court strikes down use of affirmative action

comprehensive

After affirmative action ruling, medical educators look to 'holistic review'

AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

Change Healthcare payments predicted restored March 15

PatrickSison/APChangeHealthcare’sparentcompanysaidit’llhaveitselectronicpaymentfunctionupandrunningb

The high cost of giving birth even with insurance

AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

What it’s like to watch children die of measles

AtoddlerreceivingameaslesvaccinationintheDemocraticRepublicoftheCongo.UNIORKANNAH/AFPviaGettyImagesO